Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-28

Clinical Trial Update: Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant [Phase 2]

View source ↗

Summary

Phase 2 trial update examining interactions between darunavir and rilpivirine with the etonogestrel contraceptive implant in HIV and contraception contexts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)
  • Etonogestrel Contraceptive Implant (etonogestrel)
  • rilpivirine (rilpivirine)

Snippet

Sponsor: Makerere University | Conditions: HIV, Contraception | Phase 2 | Status: UNKNOWN